Home › USFDA Tracker › Neuland Laboratories

Neuland Laboratories — USFDA Status

Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Neuland Laboratories (NSE: NEULANDLAB, BSE: 524558), from US FDA records and exchange filings.

70
Compliance score (5 years) · how
3
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified VAI — 14 Aug 2026 (Sangareddy plant). Source: FDA Data Dashboard.
USFDA events by year
2023
2024
2025
2026
NAIVAIForm 483OAIWarning letterImport alertUS approval

Plants

PlantFEILatest resultLast inspectionHistory (newest first)
Sangareddy
NEULAND LABORATORIES LIMITED
3008765255 VAI 14 Aug 2026
Sangareddy District
Neuland Laboratories Limited (Unit II)
3003309323 VAI 02 May 2025
Sangareddy
Neuland Laboratories Limited (Unit I)
3003289270 NAI 22 Mar 2024

Full USFDA timeline

14 Aug 2026
VAI — minor issues
USFDA inspection classified VAI
Sangareddy · FEI 3008765255 · NEULAND LABORATORIES LIMITED, Sangareddy — Drug Quality Assurance (Drugs)
02 May 2025
VAI — minor issues
USFDA inspection classified VAI
Sangareddy District · FEI 3003309323 · Neuland Laboratories Limited (Unit II), Sangareddy District — Drug Quality Assurance (Drugs)
22 Mar 2024
NAI — clean
USFDA inspection classified NAI
Sangareddy · FEI 3003289270 · Neuland Laboratories Limited (Unit I), Sangareddy — Drug Quality Assurance (Drugs)
26 May 2023
VAI — minor issues
USFDA inspection classified VAI
Sangareddy · FEI 3008765255 · NEULAND LABORATORIES LIMITED, Sangareddy — Drug Quality Assurance (Drugs)
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/neuland